Steinhart Richard I
CIK 0001293789
Senior VP and CFODirector
Filings
31
Latest May 22, 2026
Issuers covered
3
Showing
31 of 31
Page 1
Track record
8 of 9 open-market trades scored (89% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 8 | 88% | +7.2% | +8.0% | +21.9% | -17.3% |
| 90 days | 8 | 88% | +48.5% | +55.9% | +84.1% | -2.8% |
| 180 days | 8 | 100% | +76.8% | +78.0% | +82.1% | +69.5% |
| 365 days | 8 | 100% | +81.3% | +78.3% | +96.2% | +70.8% |
Issuers
Companies where Steinhart Richard I has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| BTAI | Bioxcel Therapeutics, Inc. | 24 | May 22, 2026 |
| ATOS | Atossa Therapeutics, Inc. | 5 | May 14, 2026 |
| ATNM | Actinium Pharmaceuticals, Inc. | 2 | Apr 2, 2025 |
All filings
31 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|